Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs061190023Completed
Open-label, single-arm trial of artificial cerebrospinal fluid in idiopathic intracranial hypotension (SIH). Primary endpoint: Change in headache severity (VAS) before and after ARTCEREB injection. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs061190023.